Measuring the effectiveness of androgen-deprivation therapy for prostate cancer in the medicare population: adequate data are neither the same as nor the enemy of perfect data
- PMID: 25023522
- DOI: 10.1001/jamainternmed.2014.1107
Measuring the effectiveness of androgen-deprivation therapy for prostate cancer in the medicare population: adequate data are neither the same as nor the enemy of perfect data
Comment on
-
Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer.JAMA Intern Med. 2014 Sep;174(9):1460-7. doi: 10.1001/jamainternmed.2014.3028. JAMA Intern Med. 2014. PMID: 25023796 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
